Discoveries · Chester and Liverpool
Chester Zoo treats 23-year-old python with electrochemotherapy in veterinary first
Veterinarians at Chester Zoo and the University of Liverpool treated a 4.5-metre reticulated python using electrochemotherapy after a malignant jaw tumour returned following surgery.
AI text based on reports by SIC Notícias, La Razón, Mediafax.ro and other publishers. Published . How it is made
For membersThe first 30 seconds for everyone. Synthetic voice (AI).
In brief
Veterinarians diagnosed 23-year-old reticulated python Jodie Foster with a malignant jaw fibrosarcoma, which returned in 2025 after an initial surgical removal in 2024.
Chester Zoo veterinary staff and University of Liverpool specialists combined the chemotherapy drug bleomycin with targeted electrical pulses during a 90-minute operation.
Staff anaesthetised the 4.5-metre, 40 to 50 kg reptile in her enclosure and pushed two operating tables together to accommodate her length.
A final veterinary check in August 2026 confirmed no cancer recurrence, with the python resuming normal feeding on whole prey.
- 2024Keepers detect jaw fibrosarcoma in Jodie Foster; vets surgically remove tumour
- 2025Tumour returns and invades jawbone, threatening python's feeding ability
- Operation dayVets complete 90-minute surgery and administer electrochemotherapy on joined tables
- August 2026Final check confirms python is cancer-free with restored feeding ability
Diagnosis and recurrence
Keepers at Chester Zoo in north-west England noticed unusual behavioural changes in Jodie Foster, a 23-year-old reticulated python measuring 4.5 metres in length. The reptile, which weighs between 40 and 50 kilograms according to veterinary records, had become inactive and showed a marked reduction in appetite. Diagnostic testing identified a fibrosarcoma, a malignant tumour located in her jawbone. Surgeons initially removed the growth in 2024, but the malignancy recurred the following year and began destroying bone tissue in the mandible. Because pythons rely on jaw mechanics to consume whole prey, the progressive bone destruction threatened the animal's life by making feeding increasingly difficult. Zoo veterinarians concluded that standard surgery would not prevent another recurrence.
Dr Ian Ashpole, veterinary officer at Chester Zoo, explained the decision to pursue alternative interventions:
“We were facing the possibility of losing her as the tumour made it more and more difficult for her to eat, so we worked with cancer specialists to see whether we could adapt electrochemotherapy for a snake. As far as we're aware, this is the first time it's ever been used in one.”
Adapted electrochemotherapy procedure
To treat the recurrent tumour, Chester Zoo collaborated with veterinary oncologists from the University of Liverpool's Department of Small Animal Clinical Science. The team selected electrochemotherapy, a clinical technique that combines the anticancer drug bleomycin with targeted electrical pulses. These short, calibrated pulses temporarily increase the permeability of cancer cell membranes, allowing the drug to penetrate more effectively and enabling the use of lower chemical doses. Managing a reptile of this size required specialized surgical logistics. Keepers and veterinary staff first anaesthetised the python inside her enclosure before moving her to the zoo's veterinary centre. Because standard equipment could not accommodate a 4.5-metre snake, two operating tables were pushed together to create a platform comparable in size to a double bed. Staff maintained the cold-blooded animal's core body temperature using warmed air and heated blankets throughout the 90-minute operation. Ashpole first excised the primary tumour mass alongside the damaged sections of jawbone, after which the team administered bleomycin and delivered the electrical pulses directly to the surgical site to eradicate residual malignant cells.
Recovery and scientific publication
Following the procedure, the python underwent monitoring to track wound healing and verify whether she could resume normal feeding habits. Pythons possess flexible jaw joints that allow them to dislocate sections of the skull to ingest large prey. Zoo keepers confirmed that the partial loss of jawbone did not compromise these mechanics, recording footage of the animal striking, seizing, and consuming whole chickens without difficulty. A final veterinary check conducted in August 2026 detected no remaining traces of cancer or further tumour growth.
“Electrochemotherapy is an emerging treatment and this was the first time it was used in a snake. The success of this treatment is a testament to the power of collaboration.”
Jose Alvarez Picornell confirmed that the clinical team plans to publish the surgical and pharmacological details in a peer-reviewed veterinary journal, providing a documented protocol for clinicians treating similar malignancies in exotic reptiles.
Ask about this text
Sources and context
- SIC NotíciasPiton de 23 anos é a primeira cobra a receber tratamento pioneiro contra o cancro
- La RazónJodie Foster, la pitón de 50 kilos que se convierte en la primera serpiente del mundo en recibir un tratamiento pionero contra el cáncer
- Mediafax.roPremieră mondială la o grădină zoologică. Un șarpe a fost tratat de cancer ca un pacient uman
- HotNews.roUn șarpe pe nume Jodie Foster a primit un tratament revoluționar împotriva cancerului folosit de obicei pentru oameni - HotNews.ro
- Jodie Foster
- American actress after whom the reticulated python was named
Pollar is free and carries no ads in the text. Its members keep it going.
Support Pollar